## **Core Concept**
The question tests knowledge of genetic factors associated with an increased risk of breast cancer. Breast cancer can be influenced by mutations in several genes, but some are more strongly associated with the disease than others. The **BRCA1** and **BRCA2** genes are well-known for their role in DNA repair and their association with hereditary breast and ovarian cancer.

## **Why the Correct Answer is Right**
The correct answer, **BRCA1**, is a tumor suppressor gene that plays a critical role in maintaining genomic stability through its involvement in DNA repair, particularly in the repair of double-strand breaks through homologous recombination. Mutations in **BRCA1** significantly increase the risk of breast and ovarian cancer. Women with a **BRCA1** mutation have a higher lifetime risk of developing breast cancer compared to the general population.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **p53** is a tumor suppressor gene and mutations in **p53** are associated with Li-Fraumeni syndrome, which increases the risk of several types of cancer, including breast cancer, the direct and significant association with breast cancer risk is more prominently linked to **BRCA1** and **BRCA2**.
- **Option B:** **HER2/neu** is an oncogene, and its overexpression is associated with a worse prognosis in breast cancer. However, it is not a germline mutation that increases susceptibility to breast cancer but rather a somatic alteration that occurs in the tumor cells.
- **Option D:** **ATM** is involved in DNA repair and is associated with ataxia-telangiectasia, a condition that increases the risk of cancer, including breast cancer. However, the most direct and significant association with breast cancer susceptibility among the options provided is with **BRCA1**.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that women with a family history of breast cancer, especially at a young age or bilateral, or those with a personal history of breast or ovarian cancer, should undergo genetic counseling and possible testing for **BRCA1** and **BRCA2** mutations. This information can guide preventive measures and screening strategies.

## **Correct Answer:** .